Status:
TERMINATED
Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Non-small Cell Lung Cancer
Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The goal of this clinical research study is to study the safety of giving larger daily doses of proton radiation therapy than the standard dose levels given to treat lung cancer. Researchers want to f...
Detailed Description
Proton Therapy: Proton therapy is a type of radiation that is designed to lower the amount of radiation given to the healthy tissue around the tumor by using a more focused beam of radiation. Radiat...
Eligibility Criteria
Inclusion
- Histologically or cytologically documented NSCLC, SCLC, thymic tumors, or carcinoid tumors
- Patients not receiving concurrent chemotherapy
- Patients that are eligible for concurrent treatment with biologic agents (epidermal growth factor receptor \[EGFR\] or vascular endothelial growth factor \[VEGF\] inhibitors) will be eligible for the study.
Exclusion
- Prior radiotherapy to the chest
- Life expectancy \<6 months
- Pregnancy
Key Trial Info
Start Date :
July 16 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 19 2016
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01165658
Start Date
July 16 2010
End Date
July 19 2016
Last Update
January 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030